Detalhe da pesquisa
1.
Compromised activity of natural killer cells in diffuse large b-cell lymphoma is related to lymphoma-induced modification of their surface receptor expression.
Cancer Immunol Immunother
; 72(3): 707-718, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36048214
2.
Grb2 regulates the proliferation of hematopoietic stem and progenitors cells.
Biochim Biophys Acta Mol Cell Res
; 1864(12): 2449-2459, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28964849
3.
Spontaneous arising of a lymphoblastoid B-cell line harbouring a pre-leukemic DNMT3A mutation in acute myeloid leukaemia cell culture.
J Cell Mol Med
; 25(22): 10778-10782, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34651440
4.
Prospective comparison of early bone marrow evaluation on day 5 versus day 14 of the "3 + 7" induction regimen for acute myeloid leukemia.
Am J Hematol
; 90(12): 1159-64, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26435038
5.
Bone marrow blast elimination by the fifth day of 7 + 3 induction is the strongest predictor of potential cure in patients with acute myeloid leukemia younger than 61 years of age: A long-term follow-up of a multi-center prospective study.
Am J Hematol
; 95(1): E3-E5, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31591736
6.
Alignment of single-cell trajectories by tuMap enables high-resolution quantitative comparison of cancer samples.
Cell Syst
; 13(1): 71-82.e8, 2022 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34624253
7.
ERK Activity in Immature Leukemic Cells Drives Clonal Selection during Induction Therapy for Acute Myeloid Leukemia.
Sci Rep
; 10(1): 8349, 2020 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32433559
8.
Proinflammatory Macrophages Promote Multiple Myeloma Resistance to Bortezomib Therapy.
Mol Cancer Res
; 17(11): 2331-2340, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31409628
9.
Characterization and activity of sonochemically-prepared BSA microspheres containing Taxol--an anticancer drug.
Ultrason Sonochem
; 14(5): 661-666, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17208504
10.
The immunomodulator AS101 induces growth arrest and apoptosis in multiple myeloma: association with the Akt/survivin pathway.
Biochem Pharmacol
; 72(11): 1423-31, 2006 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-16889755
11.
Daratumumab for eradication of minimal residual disease in high-risk advanced relapse of T-cell/CD19/CD22-negative acute lymphoblastic leukemia.
Leukemia
; 34(1): 293-295, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31435023
12.
Multiple signal transduction pathways are involved in G2/M growth arrest and apoptosis induced by the immunomodulator AS101 in multiple myeloma.
Leuk Lymphoma
; 54(1): 160-6, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22712839
13.
Induction therapy in a multiple myeloma mouse model using a combination of AS101 and melphalan, and the activity of AS101 in a tumor microenvironment model.
Exp Hematol
; 37(5): 593-603, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19375650